Id |
Subject |
Object |
Predicate |
Lexical cue |
T392 |
0-20 |
Sentence |
denotes |
Question 3 statement |
T393 |
21-279 |
Sentence |
denotes |
Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients with COVID-19 only if no important drug interactions can be anticipated and with close monitoring of hepatic function, renal function and QT prolongation. |
T394 |
280-488 |
Sentence |
denotes |
This is based on its activity in vitro against SARS-CoV-2 (although weak) and on the availability of low-level clinical evidence of anticipation of virus clearance from a small controlled nonrandomized study. |
T395 |
489-661 |
Sentence |
denotes |
However, it should also be kept in mind that the study was highly susceptible to bias and there are still no data regarding hard clinical endpoints such as crude mortality. |
T396 |
662-786 |
Sentence |
denotes |
For these reasons, hydroxychloroquine should be preferentially administered within the framework of investigational studies. |
T397 |
787-896 |
Sentence |
denotes |
When this is unfeasible, off-label use may be considered according to local protocols and consent procedures. |
T398 |
897-1093 |
Sentence |
denotes |
In view of the absence of evidence, we are currently unable to support the use of hydroxychloroquine in asymptomatic or mildly symptomatic nonhospitalized patients outside investigational studies. |
T399 |
1094-1131 |
Sentence |
denotes |
The same applies to prophylactic use. |